Literature DB >> 31918265

ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D.

Xiaobin Wang1, Qiangjun Chen2, Xi Wang3, Wensheng Li4, Guoqiang Yu4, Zhiyi Zhu4, Weitao Zhang5.   

Abstract

Prostate cancer (PCa) is a destructive malignancy with a bad prognosis. LncRNA VPS9D1-AS1 has recently been delineated as an oncogene in some kinds of tumor, whereas, the function of VPS9D1-AS1 in PCa remains to be clarified. In this study, we researched its underlying role in PCa. The expression of VPS9D1-AS1 was conspicuously upregulated in PCa tissues and cells. And absence of VPS9D1-AS1 inhibited cell proliferation, migration and invasion, and promoted cell apoptosis in PCa. In addition, VPS9D1-AS1 overexpression led to opposite results. Furthermore, VPS9D1-AS1/MEF2D could sponge with miR-4739. VPS9D1-AS1/MEF2D and miR-4739 were inversely correlated in tumor cells. And the expression of miR-4739 is markedly downregulated in PCa, meanwhile, that of MEF2D exhibited the opposite tendency. However, MEF2D was positively regulated by VPS9D1-AS1. Moreover, MEF2D upregulation offset the suppressive effects of VPS9D1-AS1 deficiency on cell proliferation, migration and invasion in PCa. Additionally, ZEB1 contained the binding sites of VPS9D1-AS1 promoter, and there existed positive relation between them. Taken together, above results illustrated that ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of PCa by sponging miR-4739 to upregulate MEF2D, which offering a new useful reference for studying the development process of PCa.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  MEF2D; Prostate cancer; VPS9D1-AS1; ZEB1; miR-4739

Year:  2019        PMID: 31918265     DOI: 10.1016/j.biopha.2019.109557

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  17 in total

1.  Long non-coding RNA NEAT1 regulates endothelial functions in subclinical hypothyroidism through miR-126/TRAF7 pathway.

Authors:  Li Wang; Jingzhi Liu; Kunna Lu; Yuyu Qiu; Xiaoxia Li; Feng Yue; Xinhuan Zhang
Journal:  Hum Cell       Date:  2021-03-07       Impact factor: 4.174

2.  Long non-coding RNA VPS9D1-AS1 promotes growth of colon adenocarcinoma by sponging miR-1301-3p and CLDN1.

Authors:  Wei Liu
Journal:  Hum Cell       Date:  2021-09-14       Impact factor: 4.374

3.  Exploring the underlying molecular mechanism of liver cancer cells under hypoxia based on RNA sequencing.

Authors:  Xin Zhao; Wenpeng Liu; Baowang Liu; Qiang Zeng; Ziqiang Cui; Yang Wang; Jinglin Cao; Qingjun Gao; Caiyan Zhao; Jian Dou
Journal:  BMC Genom Data       Date:  2022-05-19

4.  Long Noncoding RNA VPS9D1-AS1 Sequesters microRNA-525-5p to Promote the Oncogenicity of Colorectal Cancer Cells by Upregulating HMGA1.

Authors:  Hairui Liu; Xueying Zhang; Xianmei Jin; Yubo Yang; Guodong Liang; Yuehan Ma; Bing Wang
Journal:  Cancer Manag Res       Date:  2020-10-09       Impact factor: 3.989

5.  Screening a novel signature and predicting the immune landscape of metastatic osteosarcoma in children via immune-related lncRNAs.

Authors:  Jie Wei; Da-Lang Fang; Cheng Kua Huang; Shu-Liang Hua; Xiao-Sheng Lu
Journal:  Transl Pediatr       Date:  2021-07

6.  VPS9D1-AS1, a novel long-non-coding RNA, acts as a tumor promoter by regulating the miR-324-5p/ITGA2 axis in colon adenocarcinoma.

Authors:  Guohong Huang; Yimei Yang; Mengxin Lv; Tian Huang; Xiaoyan Zhan; Wei Kang; Jianghou Hou
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

7.  Identification of long non-coding RNA signatures for squamous cell carcinomas and adenocarcinomas.

Authors:  Suyan Tian; Mingbo Tang; Jialin Li; Chi Wang; Wei Liu
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

8.  Upregulation of long non-coding RNA MYU promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells.

Authors:  Shudong Gu; Li Qian; Yan Liu; Jiefei Miao; Hong Shen; Shu Zhang; Guoxin Mao
Journal:  Exp Ther Med       Date:  2021-04-18       Impact factor: 2.447

9.  LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA.

Authors:  Hongtao Zhen; Peng Du; Qiang Yi; Xiaolong Tang; Tongqing Wang
Journal:  BMC Cancer       Date:  2021-10-26       Impact factor: 4.430

10.  LncRNA VPS9D1-AS1 Promotes Malignant Progression of Lung Adenocarcinoma by Targeting miRNA-30a-5p/KIF11 Axis.

Authors:  Jiefeng Liu; Yuhua Feng; Xinyu Zeng; Miao He; Yujing Gong; Yiping Liu
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.